Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -229.07
- Piotroski Score 2.00
- Grade Buy
- Symbol (KA)
- Company Kineta, Inc.
- Price $0.81
- Changes Percentage (3.98%)
- Change $0.03
- Day Low $0.70
- Day High $0.81
- Year High $5.39
Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.
- Last Earnings N/A
- Ex-Dividend for 5/16 Dividend 12/19/2022
- Dividend Payable 12/19/2022
- Today N/A
- Next Earnings (Estimated) 10/31/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.40
- Trailing P/E Ratio -0.33
- Forward P/E Ratio -0.33
- P/E Growth -0.33
- Net Income $-14,099,000
Income Statement
Quarterly
Annual
Latest News of KA
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
The Fertile Earth by Ruthvika Rao review - illuminating tale of love and morals
Ruthvika Rao's debut novel, "The Fertile Earth," delves into family ties and forbidden friendships in post-independence India....
By The Guardian | 6 hours ago -
Cincinnati Bengals vs. Kansas City Chiefs odds, expert picks, how to watch: Cincy's gut-check continues
The Bengals face a tough challenge against the Chiefs in Week 2, with Cincinnati struggling after a disappointing loss. Joe Burrow's performance has been underwhelming, while the Chiefs show strength ...
By The New York Times | 6 hours ago -
Calculating The Intrinsic Value Of Sika AG (VTX:SIKA)
The article estimates Sika AG's intrinsic value using the Discounted Cash Flow model, indicating a 6.9% higher analyst price target. The analysis accounts for future cash flows and discount rates. How...
By Yahoo! Finance | 7 hours ago
